tm logo
STERRX
Dead/Abandoned
ABANDONED - NO STATEMENT OF USE FILED

no statement of use filed

on 15 May 2023

Last Applicant/ Owned by

141 Idaho Avenue

Plattsburgh

NY

12903

Serial Number

88637744 filed on 01st Oct 2019

Registration Number

N/A

Correspondent Address

Mark A. Paskar

BRYAN CAVE LEIGHTON PAISNER LLP

211 NORTH BROADWAY, SUITE 3600

ST. LOUIS MO 63102

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

STERRX

Pharmaceuticals, namely, oxytocics, anticholinergic agents, anticoagulants, antiemetics, beta blockers, electrolytes, general anesthetics, histamine H2 receptor antagonists, local anesthetics, loop diuretics, myocardial imaging agents and reverse agents; eye washes; irrigating solutions for eye use; saline wash for medical uses; pharmaceutical preparations for the treatment and prevention of ophthRead More

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceuticals, namely, oxytocics, anticholinergic agents, anticoagulants, antiemetics, beta blockers, electrolytes, general anesthetics, histamine H2 receptor antagonists, local anesthetics, loop diuretics, myocardial imaging agents and reverse agents; eye washes; irrigating solutions for eye use; saline wash for medical uses; pharmaceutical preparations for the treatment and prevention of ophthalmic diseases and conditions

Mark Details


Serial Number

No 88637744

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 1089178.5

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
15th May 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
15th May 2023ABANDONMENT - NO USE STATEMENT FILED
19th Oct 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
18th Oct 2022SOU EXTENSION 5 GRANTED
14th Oct 2022SOU EXTENSION 5 FILED
14th Oct 2022TEAS EXTENSION RECEIVED
02th Apr 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
31st Mar 2022SOU EXTENSION 4 GRANTED
31st Mar 2022SOU EXTENSION 4 FILED
31st Mar 2022TEAS EXTENSION RECEIVED